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Diabetes mellitus has been treated orally with herbal remedies
based on folk medicine since ancient times. Embelia ribes burm
(Myrsinaceae),knowncommonlyasvidanga,wasusedinAyurveda
for its anthelmintic activity. Ayurveda describes vidanga as pun-
gent,causesincreaseindigestiveﬁre,andcuresﬂatulenceandcolic.
A single study reported the antihyperglycemic activity of decoc-
tion of E. ribes in glucose-induced hyperglycemic albino rabbits.
In the present study, the lipid-lowering and antioxidant potential
of ethanolic extract of E. ribes burm was investigated in strepto-
zotocin (40 mg/kg, IV, single injection)-induced diabetes in rats.
Twenty days of orally feeding the extract (200 mg/kg) to diabetic
rats resulted in signiﬁcant (P<0.01) decrease in blood glucose,
serum total cholesterol, and triglycerides, and increase in HDL-
cholesterol levels when compared to pathogenic diabetic rats. Fur-
ther, the extract also lowered the liver and pancreas thiobarbituric
acid–reactive substances (TBARSs) values (P<0.01) when com-
pared to TBARS values of liver and pancreas of pathogenic dia-
betic rats. The results of test drug were comparable to gliclazide
(25 mg/kg, orally), a standard antihyperglycemic agent. This is the
ﬁrst pilot study to provide biochemical evidence of potential of E.
ribes in diabetic dyslipidemia.
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AccordingtotheFraminghamHeartStudy[1],dyslipidemia,
which can range from hypercholesterolemia to hyperlipopro-
teinemia,isoneofthemanymodiﬁableriskfactorsforcoronary
artery disease (CAD), stroke, and peripheral vascular disease.
In diabetic dyslipidemia, lipid abnormalities may be the result
of unbalanced metabolic states of diabetes (i.e., hyperglycemia
and insulin resistance).
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Improved control of hyperglycemia does moderate diabetes-
associated dyslipidemia; therefore, lipid-modifying treatment is
warranted in many diabetic patients. There is also considerable
evidence that oxidative damage is increased in diabetes, though
the mechanisms are not clear [2, 3].
Efforts continue in the ﬁeld of medicine to ﬁnd insulin sub-
stitutes from synthetic or plant sources for the treatment of dia-
betes. In traditional medicine, several medicinal plants or their
extracts have been used to treat diabetes [4].
Embelia ribes burm (family, Myrsinaceae), known com-
monly as vidanga, is used in Ayurveda as anthelmintic [5].
Ayurveda describes vidanga as pungent, causes increase in di-
gestive ﬁre, and cures ﬂatulence and colic. One Ayurvedic for-
mulation, vidangadya curna (powder of vidanga), containing
vidanga as main ingredient is taken with honey to alleviate obe-
sity [6]. In a preliminary study, Tripathi [7] reported the an-
tihyperglycemic activity of decoction of the E. ribes fruits in
glucose-fed albino rabbits. The present study was undertaken
to investigate the effect of ethanolic extract of E. ribes on di-
abetic dyslipidemia induced by streptozotocin (STZ) in wistar
rats.
MATERIALS AND METHODS
Preparation of the Extract
Dried E. ribes fruits, 200 g, were purchased locally from
a grocery shop in New Delhi, India (in India, it is commonly
available) and authenticated by a pharmacognosist, Prof. Mohd.
Ali in our institute. A voucher specimen was retained in the
department (UB # 04).
Thefruitsweresoxhletextractedwith90%ethanolinasoxh-
let apparatus for 72 hours. The solvent was removed under re-
duced pressure to give a dry extract, 7% yield w/w (with respect
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tothecrudematerial)anddoseequivalentto200mgofthecrude
drug per kilogram body weight was calculated, and suspended
in 2% v/v Tween 80 solution for the experiment.
Experimental Induction of Diabetes in Rats
Experiments on animals were conducted after obtaining ap-
proval from Hamdard University Animal Ethics Committee,
which is registered with Committee for the Purpose of Con-
trol and Supervision of Experiments on Animals (CPCSEA),
Government of India, India (Registration no. 173/CPCSEA,
dated 28 January, 2000).
Wistarratsofeithersex(150to200g)wereobtainedfromthe
central animal house facility of Hamdard University of Delhi.
They were acclimatized in an air-conditioned room at 22±C §
2±C for 7 days and provided with free access to food (Gold
Mohur rat pellet diet, Lipton India, Bangalore, India) and water.
Afterfastingfor18hours,theratswereinjectedintravenously
through tail vein with a single dose of 40 mg/kg STZ (Sigma,
St.Louis,MO,USA),freshlydissolvedincitratebuffer(pH4.5).
After injection, the rats had free access to food and water and
were given 5% glucose solution to drink overnight to counter
hypoglycemicshock.Diabetesinratswasidentiﬁedbymoderate
polydipsia and marked polyuria.
After3days,thefastingbloodglucoselevelsweredetermined
byortho-toluidinemethod[8,9].Theratsshowingfastingblood
glucose more than 200 mg/100 dL were considered diabetic and
selected for the experimentation [10, 11].
Experimental Procedure
Normal and diabetic rats (nD10 each) were randomly di-
vided into 4 groups of 10 rats each: Group I, normal healthy
control;groupII,pathogenicdiabeticcontrol(STZtreatedonly);
group III, STZ C ethanolic E. ribes extract treated (200 mg/kg);
group IV, STZ C gliclazide treated (25 mg/kg), a standard con-
trol. The test and standard drug were fed orally for 20 days.
Groups I and II rats received 2% Tween 80 solution orally once
a day for 20 days.
TABLE 1
Effect of ethanolic extract of E. ribes on STZ-diabetic rats
Serum total Serum HDL Serum
Blood glucose cholesterol cholesterol triglycerides
Groups (mg/dl) (mg/dl) (mg/dl) (mg/dl)
I Normal control 92.1 § 6.0 69.1 § 3.4 45.7 § 1.4 51.9 § 3.9
II STZ (40 mg/kg, IV) 573.9 § 29.6* 101.1 § 2.47* 33.2 § 4.39* 123.1 § 4.5*
III STZ C Ethanolic E. ribes extract 243.9 § 41.3# 81.5 § 1.25# 69.2 § 4.0# 56.9 § 4.9#
(200 mg/kg, PO)
IV STZ C gliclazide (25 mg/kg/day, PO) 248.1 § 25.8# 87.2 § 1.5# 53.9 § 3.7# 67.0 § 3.0#
Note. Values are mean § SEM (nD10).
*P<0.01 when compared with group I; #P<0.01 when compared with group II.
Blood Collection and Biochemical Estimations
On the 21st day, fasting blood samples were collected from
tail vein of all the groups of rats. Whole blood was collected
for estimation of blood glucose [8, 9]. Serum was separated
for the estimation of total serum cholesterol [12], high-density
lipoprotein (HDL)-cholesterol [13], and triglycerides [14].
Measurement of Tissue Lipid Peroxidation
On the evening of the 21st day, all fasted rats were killed by
decapitation under light ether anaesthesia. Liver and pancreas
were removed immediately and washed with ice-cold normal
saline. Ten-percent homogenate of above tissues were prepared
separately at 10,000 rpm in cooling centrifuge. Supernatant
thus obtained was used for measurement of thiobarbituric acid–
reactive substances (TBARSs), which can be measured by the
formation of malondialdehyde (MDA) after the breakdown of
polyunsaturatedfattyacids[15].Liverandpancreasproteincon-
tentswereevaluatedbythemethodofLowryusingbovineserum
albumin (BSA) as standard [16].
Statistical Analysis
The results are presented as mean § SEM using 1-way anal-
ysis of variance test (ANOVA) followed by Dunnett’s t test. P
< 0.01 was considered signiﬁcant.
RESULTS
The mean blood glucose levels in rats fed on normal diet
(group I) alone was stable throughout the experimental period.
Conversely,intheSTZ-treatedgroup,groupII,therewassignif-
icant rise in blood glucose level, as compared to group I. Drug
treatment in STZ-treated rats for 20 days signiﬁcantly reduced
(P < 0.01) blood glucose levels in groups III and IV when com-
pared to pathogenic group II rats (Table 1).
TheethanolicextractofE.ribesalsosigniﬁcantly(P<0.01)
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TABLE 2
Effect of ethanolic extract of E. ribes on tissues lipid peroxidation in STZ-diabetic rats
Lipid peroxides Lipid peroxides
(mol/mg protein) (mol/mg protein)
Groups in liver in pancreas
I Normal control 0.0441 § 0.008 0.0303 § 0.008
II STZ diabetic control (40 mg/kg, IV) 0.1861 § 0.007* 0.2019 § 0.010*
III STZ C ethanolic E. ribes extract 0.0798 § 0.001# 0.0883 § 0.006#
(200 mg/kg)
IV STZ C gliclazide (25 mg/kg) 0.0635 § 0.001# 0.0811 § 0.006#
Note. Values are mean § SEM (nD10).
*P<0.01 when compared with group I; #P<0.01 when compared with group II.
the HDL-cholesterol levels as compared to pathogenic diabetic
rats, i.e., Group II. Furthermore, the results of the test drug were
comparable to gliclazide, a standard antihyperglycemic agent.
There was no signiﬁcant change in food consumption during
the administration of ethanolic extract of E. ribes in dose of
200 mg/kg. However, the experimental animals showed marked
polyuria and moderate polydipsia.
STZtreatmentalsoinducedastatisticallysigniﬁcantincrease
in liver and pancreas lipid peroxide levels (P<0.01) as com-
pared to group I. E. ribes and gliclazide treatments lowered the
liver and pancreas TBARS values (P<0.01) as compared to
group II diabetic rats (Table 2).
DISCUSSION
Cardiovasculardiseasesconstitutethemaincauseofmorbid-
ity and mortality in diabetes mellitus. Diabetic individuals have
a 2- to 4-fold increased risk of clinical atherosclerotic disease
[17]. Dyslipidemia has been proven to be the most important
modiﬁable risk factor contributing to atherosclerosis in diabetes
[18]. Furthermore, there is widespread acceptance of a possible
role for reactive oxygen species, generated as a result of hy-
perglycemia, in causing many of the secondary complications
of diabetes, such as nephropathy, retinopathy, and neuropathy
[19].
The inability of the modern synthetic approach to provide a
satisfactoryanswerhasledtoashiftinfocustoalternativeforms
oftherapybasedondrugsderivedfromplants.Thepresentstudy




produced signiﬁcant fall in serum total cholesterol and triglyc-
eride levels, indicating profound lipid-lowering activity of the
test drug. The study also indicated the presence of antioxidant
principles in the extract.
In conclusion, the present study shows that increased ox-
idative stress is apparent in STZ-induced diabetic animals. The
ethanolic extract of E. ribes can protect tissues from lipid per-
oxidation. The extract also exhibits a signiﬁcant lipid-lowering
activity in these rats. Further studies are being undertaken to
explain more fully the mechanism(s) of the lipid-lowering and
antioxidant effects of E. ribes.
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